REPROS THERAPEUTICS INC.: accounts_payable
| Value | {"amount": 3221000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-03-31) |
| Status | current |
| Entity | REPROS THERAPEUTICS INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/04035d88-2a21-412d-b649-3b93fac906f8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-13-027766 · Open the official SEC filing →Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000897075/accounts-payable/2013-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/04035d88-2a21-412d-b649-3b93fac906f8
History
- no predecessors — first report